Your browser doesn't support javascript.
loading
Comprehensive Clinical and Laboratory Follow-up of a Female Patient With Ebola Virus Disease: Sierra Leone Ebola Virus Persistence Study.
Liu, William J; Sesay, Foday R; Coursier, Antoine; Knust, Barbara; Marrinan, Jaclyn E; Whitmer, Shannon; McDonald, Suzanna L R; Gaillard, Philippe; Liu, Yang; Su, Qiudong; Zhang, Yong; Crozier, Ian; Ariyarajah, Archchun; Carino, Marylin; Massaquoi, Thomas; Broutet, Nathalie; Xu, Wenbo; Wu, Guizhen; Ströher, Ute; Gao, George F; Formenty, Pierre; Sahr, Foday; Deen, Gibrilla F.
Afiliación
  • Liu WJ; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Sesay FR; The Sierra Leone Ministry of Defense, Freetown, Sierra Leone.
  • Coursier A; World Health Organization, Geneva, Switzerland.
  • Knust B; Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Marrinan JE; World Health Organization, Geneva, Switzerland.
  • Whitmer S; Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • McDonald SLR; World Health Organization, Geneva, Switzerland.
  • Gaillard P; World Health Organization, Geneva, Switzerland.
  • Liu Y; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Su Q; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang Y; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Crozier I; World Health Organization, Geneva, Switzerland.
  • Ariyarajah A; World Health Organization, Geneva, Switzerland.
  • Carino M; World Health Organization, Geneva, Switzerland.
  • Massaquoi T; The Sierra Leone Ministry of Defense, Freetown, Sierra Leone.
  • Broutet N; World Health Organization, Geneva, Switzerland.
  • Xu W; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wu G; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Ströher U; Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Gao GF; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Formenty P; World Health Organization, Geneva, Switzerland.
  • Sahr F; The Sierra Leone Ministry of Defense, Freetown, Sierra Leone.
  • Deen GF; The Sierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone.
Open Forum Infect Dis ; 6(3): ofz068, 2019 Mar.
Article en En | MEDLINE | ID: mdl-30949523
ABSTRACT
The clinical, virologic, and immunologic findings in a female Ebola virus disease patient are described. During the long-term follow-up, Ebola virus RNA was detectable in vaginal fluid before 36 days after symptom onset, with nearly an identical genome sequence as in acute phase blood. Ebola-specific T cells retained activation at 56 days after disease onset.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2019 Tipo del documento: Article País de afiliación: China